Skip to main content

Jiawei Zhou, PhD, is a UNC Lineberger Comprehensive Cancer Center member with research interests in integrating pharmacometrics and machine learning to understand tumor heterogeneity and develop precision medicine for cancer patients.

PhD
Assistant Professor, Pharmacotherapy and Experimental Therapeutics
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

My research interest focuses on two research areas:

  1. Integrating pharmacometrics and quantitative system pharmacology with AI/machine learning to optimize oncology clinical trials and enhance cancer patient care
  2. Advancing mRNA lipid-nanoparticle (LNP) therapeutics: leveraging engineering and pharmacometrics modeling tools to develop and translate this new modality across diverse disease areas

Find publications on PubMed

Awards and Honors

  • Travel Award, Society for Industrial and Applied Mathematics, 2022
  • Research & Graduate Education Retreat Best 3-Minute Presentation Award, UNC-Chapel Hill, 2022
  • The J. Heyward Hull Award, UNC-Chapel Hill, 2022
  • The GSK Fellowship, UNC-Chapel Hill, 2021
  • Student Poster Award, ACoP12 SxP SIG, 2020
  • UNC Lineberger Comprehensive Cancer Center Third Place – Clinical Research, UNC-Chapel Hill, 2019
  • The Eshelman Fellowship, UNC-Chapel Hill, 2018
Headshot of Jiawei Zhou